-
Prof Yarin Gal. The postholder will work in the Department of Computer Science at the University of Oxford, based in the Wolfson Building, Parks Road, Oxford. The postholder is expected to conduct
-
, computational modelling, and in vivo physiology—to dissect cholesterol‑mediated modulation of key receptors like Glucagon receptor and GLP‑1R, with direct relevance to metabolic disease therapeutics. The Siebold
-
will have or be close to the completion of a PhD in Neuroscience, Psychology or a closely related discipline. With in-depth knowledge of cognitive and computational neuroscience including motivation
-
base, the partnership will bring together the University of Oxford’s expertise in statistics, mathematics, engineering and AI with industry scientists. Within the partnership, small research teams will
-
and science exploitation of the MIGHTEE survey data. The postholder would have the opportunity to identify new discoveries in the data and would be ideally placed to lead the science based on the data
-
to study health and disease. Accordingly, almost all of contemporary biological science research is critically dependent on our ability to identify which genes are related in different species. The Kelly
-
We are seeking a talented and motivated researcher to join the Mead Group to contribute to a major research programme, focused on understanding and preventing disease progression in
-
Leedham (colorectal cancer biology), Dan Woodcock (cancer genomics), Helen Byrne (mathematical modelling), and Jens Rittscher (computational pathology and imaging AI), offering a unique opportunity to work
-
posters locally and at national and international conferences, as well as participate in MRC grant’s research programme led by Prof Marco Fritzsche. You must hold a relevant PhD/DPhil (or be near completion
-
Institute for Molecular and Computational Medicine (IMCM). You will test GSK assets and targets in established models of podocyte and mesangial cell pathology relevant to glomerular diseases. You will